Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications
- 1 March 2012
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 125 (3) , 302.e1-302.e7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide studyEuropean Heart Journal, 2011
- Four-Dollar Generics — Increased Accessibility, Impaired Quality AssuranceNew England Journal of Medicine, 2010
- Regulatory Action on Rosiglitazone by the U.S. Food and Drug AdministrationNew England Journal of Medicine, 2010
- Patients’ Perceptions Of Generic MedicationsHealth Affairs, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular CausesNew England Journal of Medicine, 2007
- Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2006
- Projection of Diabetes Burden Through 2050Diabetes Care, 2001
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998